These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6794924)

  • 1. Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin-C treatment.
    Agnelli G; Gresele P; Nenci GG
    Cancer Chemother Pharmacol; 1981; 5(3):205-6. PubMed ID: 6794924
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
    Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
    Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
    De Jager RL; Magill GB; Golbey RB; Krakoff IH
    Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
    [No Abstract]   [Full Text] [Related]  

  • 5. Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil.
    Spencer HJ
    J Surg Oncol; 1984 May; 26(1):47-50. PubMed ID: 6328125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.
    Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK
    Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced gastric cancer with 5-fluorouracil versus mitomycin C.
    Gupta S
    J Surg Oncol; 1982 Oct; 21(2):94-6. PubMed ID: 6752585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of combination chemotherapy for pancreatic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
    Bruckner HW; Storch JA; Brown JC; Goldberg J; Chamberlin K
    Oncology; 1983; 40(3):165-9. PubMed ID: 6405338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
    Bruckner HW; Kalman J; Spigelman M; Gorbaty MI; Butwell N; Storch J; McKenna A
    Oncology; 1989; 46(6):366-71. PubMed ID: 2511535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C.
    Singh K; Egbert PR; Byrd S; Budenz DL; Williams AS; Decker JH; Dadzie P
    Am J Ophthalmol; 1997 Jan; 123(1):48-53. PubMed ID: 9186096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.
    Harvey JH; Smith FP; Schein PS
    J Clin Oncol; 1984 Nov; 2(11):1245-8. PubMed ID: 6092556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin and fluorouracil with concomitant radiotherapy in head and neck cancer.
    Kaplan MJ; Hahn SS; Johns ME; Stewart FM; Constable WC; Cantrell RW
    Arch Otolaryngol; 1985 Apr; 111(4):220-2. PubMed ID: 3977753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C.
    Jones BG; Fielding JW; Newman CE; Howell A; Brookes VS
    Lancet; 1980 Jun; 1(8181):1275-7. PubMed ID: 6104085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.